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Abstract It has been demonstrated that stress impairs perfor-
mance of skilled reaching and walking tasks in rats due to the
action of glucocorticoids involved in the stress response.
Skilled reaching and walking are controlled by the primary
motor cortex (M1); however, it is not known whether stress-
related impairments in skilled motor tasks are related to func-
tional and/or structural alterations within the M1. We studied
the effects of single and repeated injections of corticosterone
(twice daily for 7 days) on spontaneous excitatory and inhib-
itory postsynaptic currents (sEPSCs and sIPSCs) recorded
from layer II/III pyramidal neurons in ex vivo slices of the
M1, prepared 2 days after the last administration of the hor-
mone. We also measured the density of dendritic spines on
pyramidal cells and the protein levels of selected subunits of
AMPA, NMDA, and GABAA receptors after repeated corti-
costerone administration. Repeatedly administered corticoste-
rone induced an increase in the frequency but not in the am-
plitude of sEPSCs, while a single administration had no effect
on the recorded excitatory currents. The frequency and ampli-
tude of sIPSCs as well as the excitability of pyramidal cells
were changed neither after single nor after repeated cortico-
sterone administration. Treatment with corticosterone for
7 days did not modify the density of dendritic spines on pyra-
midal neurons. Corticosterone influenced neither the protein
levels of GluA1, GluA2, GluN1, GluN2A, and GluN2B sub-
units of glutamate receptors nor those of α1, β2, and γ2
subunits of the GABAA receptor. The increase in sEPSCs
frequency induced by repeated corticosterone administration
faded out within 7 days. These data indicate that prolonged
administration of exogenous corticosterone selectively and
reversibly enhances glutamatergic, but not GABAergic trans-
mission in the rat motor cortex. Our results suggest that corti-
costerone treatment results in an enhancement of spontaneous
glutamate release from presynaptic terminals in the M1 and
thereby uncovers a potential mechanism underlying stress-
induced motor functions impairment.
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Introduction
In the rat brain, the primary motor cortex (M1) contains motor
maps, which are representations of how movements are orga-
nized [8, 32]. Examples of M1-controlled motor functions in
the rat include skilled limb use in reaching for food [49] and in
rung ladder walking [1]. Motor skill learning is associated
with a reorganization of movement representations within
the rat M1 [19, 36]. The mechanism of motor skill learning-
related plasticity of the M1 involves activity-dependent, long-
term strengthening of excitatory synaptic connections within
the cortical layer II/III [37–39]. Motor skill learning has also
been reported to induce an increase in synapse number in the
M1 [20]. It has been shown that acute and chronic stress im-
pairs the movement accuracy in skilled reaching and walking
tasks and alters skilled movement patterns in the reaching task
[21, 29]. Stress-related impairments in skilled motor tasks
may be related to functional and/or structural plasticity of
excitatory synapses within rat M1; however, this possibility
has not yet been investigated.
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While the effects of acute stress on the brain are usually
transient, chronic stress is thought to exert a persistent, detri-
mental influence, which is generally attributed to a prolonged
hyperactivation of the hypothalamic–pituitary–adrenal (HPA)
axis and an elevated level of corticosteroids acting at the cel-
lular level through glucocorticoid and mineralocorticoid re-
ceptors (GRs and MRs, respectively; reviewed in [5, 25,
33]). Repeated stress has been reported to induce suppression
of glutamatergic transmission and a decrease in the expression
level of glutamate receptors and synaptic proteins in the rat
medial prefrontal cortex (mPFC), which is an important target
for glucocorticoids involved in the stress response [24, 51].
Moreover, repeated stress results in profound morphological
changes of pyramidal neurons in the mPFC (reviewed in [41]).
GR and MR receptors are expressed in the rat M1 [30, 40],
and it has been reported thatMR andGR blockade ameliorates
motor impairments resulting from stress [15]. However, the
effects of stress on the structure and function of the rat motor
cortex remain largely unknown.
Since 21 days of repeated corticosterone injections reliably
increase depression-like behavior [11], repeated corticoste-
rone administration has been proposed as a preclinical rat
model of chronic stress (reviewed in [42]). One advantage of
this model is that it directly examines the influence of an
elevated level of corticosterone on the organism in contrast
to different paradigms of repeated behavioral or social stress.
Similar to repeated restraint stress, repeated administration of
exogenous corticosterone impairs the movement accuracy in
skilled reaching and walking tasks [21, 29]. We have previ-
ously investigated the effects of repeated corticosterone ad-
ministration lasting 7 and 21 days, on field potentials evoked
in layer II/III of the rat motor cortex [4]. We have reported that
corticosterone treatment resulted in an increase in the field
potential amplitude which occurred within less than 7 days
of corticosterone administration and persisted during the fol-
lowing 2 weeks of the treatment. This effect was accompanied
by an increase in the mean frequency of spontaneous excitato-
ry postsynaptic currents (sEPSCs) in layer II/III pyramidal
neurons, collectively suggesting an enhancement of excitatory
synaptic transmission due to corticosterone treatment.
The aim of the present study was to determine whether the
repeated corticosterone administration-induced functional
changes in the M1 excitatory synaptic transmission are asso-
ciated with structural modifications. To this end, we measured
the density of dendritic spines in layer II/III pyramidal neurons
in control and corticosterone-treated rats. Since stress has pre-
viously been reported to induce an increase in the level of
GABAergic markers in rat mPFC [9], we also aimed at finding
if corticosterone treatment lasting 7 days influences spontane-
ous inhibitory postsynaptic currents (sIPSCs) in M1 layer II/
III pyramidal cells. Moreover, we have also investigated the
effects of a single administration of corticosterone on sEPSCs
and sIPSCs and assessed the influence of prolonged
corticosterone treatment on the protein level of selected sub-
units of AMPA, NMDA, and GABAA receptors.
Experimental procedures
Animals and treatment
Experimental procedures were approved by the Animal Care
and Use Committee at the Jagiellonian University and were
carried out in accordance with the European Community
guidelines for the use of experimental animals and the national
law. Male Wistar rats, aged 5–6 weeks at the beginning of the
experiment, were housed in groups and maintained on a 12-h
light/dark schedule (light on: 0800–2000 hours). Standard
food and tap water were available ad libitum. Animals were
weighed on a daily basis. Corticosterone (Sigma-Aldrich),
suspended in 1 % Tween 80, was administered subcutaneous-
ly (dose 10mg/kg, volume 2ml/kg) either once (termed: 1× or
single administration) or twice daily, for 7 days (termed 7d or
repeated administration [52]). Control animals received the
vehicle (termed Tw or Tween), but otherwise they were han-
dled identically and were investigated concurrently with
corticosterone-treated rats.
Tissue preparation
In most experiments, brain slices were prepared 2 days after
the last corticosterone administration to avoid acute effects of
the hormone. In two sets of experiments, slices were prepared
4 or 7 days after the end of corticosterone treatment. Rats were
anesthetized with isoflurane (Aerrane, Baxter) and decapitat-
ed. Their brains were quickly removed and placed in ice-cold
artificial cerebrospinal fluid (ACSF) containing (in mM): 130
NaCl, 5 KCl, 2.5 CaCl2, 1.3 MgSO4, 1.25 KH2PO4, 26
NaHCO3, and 10 D-glucose and bubbled with the mixture of
95 % O2–5 % CO2. Coronal, frontal cortical slices (thickness
400 μm) containing a part of M1 were cut from one of the
hemispheres between 3.5 and 1.7 mm rostral to bregma using
a vibrating microtome (Leica VT1000). Slices were stored
submerged in ACSF at 30± 0.5 °C. Primary motor cortex
(3.5–1.7 mm rostral to bregma and 2.0–3.5 mm lateral to the
midline) from the other hemisphere was dissected on ice and
cryopreserved at −80 °C for later Western blotting analysis.
In order to exclude the influence of lateralization, the brain
hemispheres were used alternately for electrophysiology and
Western blotting.
Whole-cell recording
Individual slices were placed in the recording chamber
mounted on the stage of the Zeiss Axio Examiner. D1 micro-
scope and superfused at 3 ml/min with warm (32±0.5 °C),
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modified ACSF of the following composition (in mM): 132
NaCl, 2 KCl, 1.25 KH2PO4, 26 NaHCO3, 1.3 MgSO4, 2.5
CaCl2, and 10 D-glucose 10, bubbled with 95 % O2–5 %
CO2. Recording pipettes were pulled from borosilicate glass
capillaries (Harvard Apparatus) using the Sutter Instrument
P97 puller. The pipette solution contained (in mM): 130 K-
gluconate, 5 NaCl, 0.3 CaCl2, 2 MgCl2, 10 HEPES, 5 Na2-
ATP, 0.4 Na-GTP, 1 EGTA, and 0.1 % biocytin (osmolarity
290 mOsm, pH 7.2). Pipettes had open tip resistance of
approx. 6 MΩ. Pyramidal cells were sampled from sites locat-
ed at least 2 mm lateral to the midline and approx. 0.3 mm
below the pial surface and were identified, as described pre-
viously [45]. Signals were recorded using the SEC 05LX am-
plifier (NPI, Germany), filtered at 2 kHz, and digitized at
20 kHz using Digidata 1440A interface and Clampex 10 soft-
ware (Molecular Devices, USA).
Electrophysiological characteristics of neurons
After obtaining the whole-cell configuration and subsequent
10-min stabilization period, the firing characteristics of the
recorded cells were assessed using intracellular injections of
rectangular current pulses of increasing amplitude (duration
400 ms, Fig. 1b) in the current clamp mode. For each cell, the
relationship between injected current intensity and the number
of spikes was plotted. The gain was determined as a slope of
the straight line fitted to experimental data (Fig. 1c; cf. [3]).
The threshold current (Ith) was determined as a current extrap-
olated at zero firing rate (Fig. 1c).
Recording and analysis of sEPSCs and sIPSCs
To record spontaneous EPSCs, neurons were voltage-clamped
at −76 mV and synaptic events were recorded for 4 min as
inward currents (Fig. 2a, b). Next, cells were voltage-clamped
at 0 mVand after 15 min of stabilization period, sIPSCs were
recorded for 4 min as outward currents (Fig 3a, b) [44]. This
approach allowed us to record from the same neuron without a
need to change the recording micropipette solution. Since this
method requires high amplitude current injections, what re-
sults in a greater noise level, the smaller number of sIPSCs
than sEPSCs recordings was suitable for further analysis. In
order to block excitatory synaptic transmission, in a separate
set of experiments, sIPSCs were recorded in the ACSF sup-
plemented with 2 mM kynurenic acid.
Spontaneous EPSCs and IPSCs were detected offline using
the automatic detection protocol (Mini Analysis software,
Synaptosoft Inc.) and subsequently checked manually for ac-
curacy. Data were accepted for the analysis when the access
resistance ranged between 15 and 18 MΩ, and it was stable
(<25% change) during recording. The threshold amplitude for
the detection of an EPSC was set at 5 pA, and for IPSCs, the
detection threshold was set at 10 pA.
Imaging and deconvolution
Following whole-cell patch clamp recordings with biocytin
filling of recorded cells, slices were fixed for 24 h in 4 %
formaldehyde in PBS. After several washings, tissue was in-
cubated in phosphate-buffered saline containing 0.6 %
Triton X-100 (Sigma-Aldrich) for 24 h and subsequently with
0.3 % Triton X-100 and Cy3-conjugated ExtrAvidin (1:200;
Sigma-Aldrich) for 48 h. Slices were washed and mounted
on glass slides, coverslipped with Vectashield containing
DAPI (Vector Laboratories), and examined using the Zeiss
LSM510META confocal microscope (Microimaging GmbH,
Jena, Germany). The selection scheme of dendritic segments
for the spine counting was planned to minimize any possible
bias. The imaging conditions were the following: 543-nm ex-
citation wavelength generated by HeNe green laser attenuated
to 60 % of its full power with Acusto-Optical Filter (AOF),
488/543 dichroic mirror to reflect excitation light to the oil
immersion 63×/1.4 Plan Apochromat objective (Zeiss, Ger-
many), 560 LP emission filter, and PMTwith gain and offset
adjusted to image the specimens without the clipping effect.
The set of optical slices was taken for each specimen at pin-
hole aperture open to 1 Airy unit (106 μm pinhole diameter),
35 μs pixel time, and 604×604 pixels of image resolution
under the 5× digital zoom to obtain Nyquist sampling criteri-
on—X=47 nm, Y=47 nm, and Z=160 nm. The experimental
point spread function (PSF) for the microscope optical ar-
rangement was calculated using images of 0.175-μm fluores-
cent beads (PS-Speck Microscope Point Source Kit (P7220),
Life Technologies, USA). Huygens Professional software
(version 4.2, SVI, Netherlands) was used for image
deconvolution. PSF was calculated on the basis of at least 25
distilled and accumulated images of the beads followed by
object stabilizer approach. Then, all optical sections of fluo-
rescently tagged cells imaged in the confocal microscope (see
above) were deconvolved at signal-to-noise ratio (SNR) value
set to 20. Finally, the images were saved for manual spine
counting from the optical stacks. Every protrusion considered
to be a spine was verified on the basis of a 3D projection
constructed from the stack in ImageJ (NIH). Data analyses
were performed by an experimenter blinded to the treatment
condition.
Western blotting
The GluA1 and GluA2 subunits were chosen for the analysis
since it has been estimated that more than 80 % of native
AMPA receptors are GluA1A2 heteromers [26, 35]. For
NMDA and GABAA receptors, we chose GluN1; GluN2A;
GluN2B; and α1, β2, γ2 subunits, respectively, since synaptic
receptors containing these subunits are most abundant in the
cortex [6, 17, 27].
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Cortical tissue samples were thawed and homogenized
with Ultra Turrax T25 (Janke & Kunkel IKA-47
Labortechnik) in 300 μl of ice-cold solution of RIPA buffer
(Sigma-Aldrich) containing phenylmethane–sulfonyl fluo-
ride, sodium orthovanadate, Protease Inhibitor Cocktail,
Phosphatase Inhibitor Cocktails 1 and 2 (Sigma-Aldrich),
and 5 % glycerol. The homogenate was centrifuged (14,
000×g, 4 °C) for 20 min to obtain the crude membrane
fraction. Protein concentration was determined using the col-
orimetric technique and BCA protein assay kit (Pierce,
Rockford, IL). A standard curve was generated and then
absorbance of samples was measured with the Multiskan
Spectrum microplate spectrophotometer (Thermo
Labsystems). Supernatants from all the samples were diluted
with RIPA buffer to obtain the same protein concentration in
150 μl of the solution. Samples were boiled for 7 min at
99 °C in Laemmli (Bio-Rad) sample buffer with 2-
mercaptoethanol (Sigma-Aldrich). Protein samples were an-
alyzed by Western blotting, as described previously [48].
Afterwards, the membranes were incubated with affinity-
purified polyclonal antibodies against AMPA, NMDA, and
GABAA receptor subunits: GluA1 and GluA2 (1:1000, rab-
bit; Millipore), GluN1, GluN2A, GluN2B (1:200; goat;
Santa Cruz Biotechnology Inc.) in 3 % non-fat dry milk–
TBST as well as GABAA receptor subunits: α1 (1:200, goat;
Santa Cruz Biotechnology Inc.) and β2, γ2 (1:1000, rabbit;
Millipore) in 1 % bovine serum albumin (BSA)–TBST at
4 °C overnight. On the next day, membranes were incubated
with horseradish peroxidase-conjugated secondary antibody
(1:2000, Vector Laboratories) in 3 % non-fat dry milk or
1 % BSA–TBST, for 60 min at room temperature. The sec-
ondary antibody used for the GluN1, GluN2A, GluN2B, and
α1 subunit was an anti-goat antibody, whereas the secondary
antibody used for the GluA1, GluA2, β2, and γ2 subunits
was an anti-rabbit antibody. Proteins were detected using a
chemiluminescent method (Immun-Star HRP). Results were
normalized to GAPDH (36 kDa), using a GAPDH loading
control mouse antibody (1:1000; Thermo Fisher Scientific
Inc.).
Statistics
Statistical analysis of electrophysiological data was carried out
using two-way ANOVA with post hoc Holm–Sidak method
and post hoc Tukey test for the assessment of the longevity of
corticosterone effects. Cumulative inter-event interval and
amplitude distributions of postsynaptic events were compared
using the Kolmogorov–Smirnov (KS) test. Western blotting
and spine density data were evaluated using Student’s t test.
Rats were weighted on a daily basis, and body mass was
analyzed using repeated measures two-way ANOVA.
p<0.05 was considered as statistically significant.
Fig. 1 Corticosterone administration does not influence the intrinsic
excitability of layer II/III pyramidal neurons. a Representative image
showing biocytin-filled pyramidal cell after patch-clamp recording;
scale bar = 100 μm. b Responses of a representative cell to sub- and
suprathreshold depolarizing current pulses. c Graph of the number of
action potentials vs. injected current for the cell shown in b. The
threshold current (Ith) corresponds to the extrapolated current at zero
firing rate. The slope of the straight line fitted to experimental data
represents gain. d Mean (±SEM) gain for control neurons (Tw) and
neurons from corticosterone-treated animals (Cort), receiving injections
once (1×) or repeatedly for 7 days (7d). e Mean (±SEM) threshold
current. Labels as in d
Fig. 2 Repeated corticosterone-induced increase in the frequency of
sEPSCs in layer II/III pyramidal cells. a Sample recordings in the
ACSF of sEPSCs from representative neurons in slices prepared from
the animal receiving vehicle (Tw, upper trace) and corticosterone for
7 days (Cort, lower trace). b Sample recordings from representative
neurons in a slice prepared from control animal before (upper trace)
and after (lower trace) addition of 2 mM kynurenic acid (KYN) to the
ACSF. c Averaged sEPSCs, recorded over a period of 4 min from cells
shown in a (1—Tween; 2—corticosterone-treated). d1–e2 Averaged
cumulative histograms of inter-event intervals (±SEM) and amplitudes
of sEPSCs recorded from control cells (Tw, open circles) and from
neurons from corticosterone-treated rats (Cort, filled circles) receiving
injections once (1×, d1, d2) or repeatedly (7d, e1, e2). Insets—bar
graphs illustrating a comparison of the mean frequency and the mean
amplitude (± SEM) of sEPSCs recorded from neurons from control
(white bars) and corticosterone-treated rats; once (1×—gray bars) or
repeatedly (7d—black bars). ***p < 0.001. f Sample recordings of
sEPSCs from a representative neuron in slice prepared from the animal
receiving corticosterone for 7 days. Upper trace—recording in standard
ACSF and in the presence of TTX (lower trace). g1, g2 Mean frequency
of sEPSCs in individual neurons before and after addition of TTX to
the ACSF in slices prepared from control (g1) and corticosterone-
treated (g2) rats
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Results
Corticosterone and neuronal excitability
Control and corticosterone-treated rats had similar body mass
after single and after repeated administration (1× Tween,
142.5 ± 9.7 g; 1× Cort, 131.0 ± 9.3 g; t (17) = 0.754,
p = 0.462; and 7d Tween, 190.9 ± 9.2 g; 7d Cort, 171.0
±9.3 g; t (17)=1.532, p=0.144, respectively).
All recorded cells exhibited a regular spiking firing pattern
in response to a depolarizing current pulse, typical of pyrami-
dal neurons (Fig. 1b). There were no statistically significant
differences between neurons originating from corticosterone-
treated groups of animals and respective control cells either in
the resting membrane potential or in the input resistance
(Table 1). To assess the intrinsic excitability, the relationship
between the firing rate and the intensity of the injected current
was evaluated for each neuron (Fig. 1c). As illustrated in
Fig. 1d, e, neither the mean gain nor the mean threshold value
of action potential generation differed between experimental
and control groups, indicating that corticosterone treatment did
not influence the excitability of layer II/III pyramidal neurons.
Effects of corticosterone on sEPSCs and sIPSCs
A single injection of corticosterone affected neither the mean
frequency nor the mean amplitude of sEPSCs (Fig. 2d1, d2;
Table 2). The occurrence of spontaneous EPSCs could be
blocked by 2 mM kynurenic acid (Fig. 2b). Amplitudes and
inter-event interval times of sEPSCs were plotted as cumula-
tive distribution histograms (Fig. 2d–e). Cumulative distribu-
tion of both amplitudes and inter-event interval intervals of
sEPSCs did not differ between control and corticosterone-
treated groups (KS test, p>0.05). However, in slices originat-
ing from rats treated with corticosterone for 7 days and pre-
pared 2 days after the last hormone administration, the mean
frequency, but not the mean amplitude of sEPSCs, was mark-
edly higher than that in the cells originating from control an-
imals receiving vehicle (Fig. 2e1, e2; Table 2). These findings
were validated by comparing data from the respective cumu-
lative distribution histograms of sEPSCs frequencies (KS test,
p<0.001, Fig. 2e1) and amplitudes (KS test, p=0.8, Fig. 2e2).
The rise time and the decay time constant of the averaged
sEPSCs were similar in both groups (Fig. 2c, Table 2).
To test the contribution of action potential-related gluta-
mate release to recorded sEPSCs, the effect of Na+ channel
Table 1 Basic parameters of recorded neurons (mean ± SEM)
Group Vm (mV) Rm (MΩ) n
1× Tween −70.85 ± 1.27 47.46 ± 4.29 13
1× Corticosterone −71.27 ± 0.78 58.58 ± 6.29 15
7d Tween −69.39 ± 1.32 50.59 ± 6.81 19
7d Corticosterone −69.00 ± 1.04 56.85 ± 6.18 19
Differences between values for neurons in experimental (corticosterone)
and control (Tween) groups, receiving injections once (1×) or repeatedly
for 7 days (7d) are not significant (p > 0.05).
Vm resting membrane potential, Rm input resistance, n number of cells













1× Tween 1.17± 0.19 9.66± 0.38 2.75± 0.14 10.71 ± 0.76 14
1× Corticosterone 1.36± 0.23 9.63± 0.38 2.68± 0.12 10.36 ± 0.78 15
7d Tween 1.16± 0.10 9.76± 0.28 2.80± 0.08 10.13 ± 0.48 19
7d Corticosterone 2.09± 0.30 *** 9.68± 0.39 2.64± 0.13 9.68 ± 0.44 19
***p < 0.001 indicates a significant difference between experimental (corticosterone) and control (Tween)
groups, receiving injections once (1×) or repeatedly for 7 days (7d)
n number of cells
Fig. 3 Lack of the effect of corticosterone on sIPSCs in layer II/III
pyramidal cells. a Sample recordings of sIPSCs from representative
neurons in slices prepared from the animal receiving vehicle (upper
trace) or corticosterone for 7 days (lower trace). b Sample recordings
from representative neurons in a slice prepared from control animal
before (upper trace) and after addition of 20 μM bicuculline (BIC) to
the ACSF (lower trace). c Averaged sIPSCs, recorded over a period of
4 min, from cells shown in a (1—Tween; 2—corticosterone-treated). d1,
e1 Averaged cumulative histograms of inter-event intervals (±SEM) of
sIPSCs recorded in control cells (Tw, open circles) and in neurons from
corticosterone-treated rats (Cort, filled circles) receiving injections once
(1×) or repeatedly for 7 days (7d). d2–e2Averaged cumulative histograms
of amplitudes (±SEM) of sIPSCs. Labels as in d1, e1. Insets in d1–e2—bar
graphs illustrating a comparison of the mean frequency and the mean
amplitude (± SEM) of sIPSCs recorded from neurons from control
(white bars) and corticosterone treated rats; once (1×—gray bars) or
repeatedly (7d—black bars). f Sample recording of sIPSCs from a
representative neuron in a slice prepared from control animal before
(upper trace) and after (lower trace) addition of 2 mM kynurenic acid
to the ACSF. g1 Mean frequency (± SEM) of sIPSCs recorded from
individual neurons before and after addition of 2 mM kynurenic acid
(KYN) to the ACSF in slices prepared from control (7d Tw) and
corticosterone-treated (7d Cort) rats. The differences are not statistically
significant. g2Mean amplitude (± SEM) of sIPSCs recorded in individual
neurons before and after addition of 2 mM kynurenic acid (KYN) to the
ACSF. Labels as in g1
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blocker tetrodotoxin (TTX) was investigated in a separate
sample of 6 control and 9 neurons obtained from
corticosterone-treated (7d) animals (Fig. 2f). The addition of
0.5 μM TTX to the ACSF did not change either the mean
frequency (Tween, 1.43±0.18 Hz; in TTX, 1.14±0.20 Hz; t
(5) =2.061, p=0.094; see Fig. g1, and Cort 2.22±0.16 Hz; in
TTX, 2.03±0.14 Hz; t (8)=1.634, p=0.141; see Fig. 2g2) or
the mean amplitude (Tween, 14.26±0.89 pA; in TTX, 12.27
±0.59 pA; t (5) =1.570, p=0.096, and Cort 13.82±0.56 pA;
in TTX, 12.91±0.48 pA; t (8)=1.362, p=0.21) of sEPSCs.
Thus, it is likely that most of sEPSCs recorded in the present
study correspond to miniature EPSCs (mEPSCs).
Corticosterone administration had no effect on parameters
characterizing spontaneous IPSCs, which could be blocked by
20 μM bicuculline (Fig. 3b). Both the frequency and ampli-
tude (Fig. 3d1–e2) as well as the rise time and the decay time
constant of sIPSCs (Fig. 3c, Table 3) were not significantly
different from control values in any of the experimental
groups. Concordantly, corticosterone treatment altered neither
the inter-event interval (Fig. 3e1, e2, KS test, p=0.5) nor the
amplitude (Fig. 3e1, e2, KS test, p = 0.9) distribution of
sIPSCs.
To exclude the possibility that sEPSCs contributed to
spontaneous synaptic activity recorded at 0 mV, in a sep-
arate set of recordings (9 cells originating from 4 rats
receiving Tween for 7 days, 10 cells from 5 rats receiving
corticosterone for 7 days), 2 mM kynurenic acid was
added to the ACSF (Fig. 3f). As illustrated in Fig. 3g1,
g2, neither the mean frequency nor the mean amplitude of
postsynaptic events recorded from neurons originating
both from corticosterone-treated and control animals was
affected by the blockade of glutamatergic transmission.
Corticosterone and the density of dendritic spines
For the dendritic spine counting, 11 neurons originating from
rats treated with corticosterone for 7 days and 9 cells obtained
from control animals were analyzed. The dendritic spines
were counted on the total length of 1961.5 μm on 43 indepen-
dent secondary, tertiary, and quaternary dendritic branch
segments from the corticosterone group and on 1202.5 μm
on 32 segments from the control group, within 10–90 μm
from the soma. In total, 2496 spines on cortical neurons from
corticosterone-treated animals and 1379 spines on cortical
neurons from control animals were analyzed. The overall
spine density did not differ significantly between the groups
(1.2 ± 0.09 vs. 1.12 ± 0.07 spines/μm, respectively; p=0.5,
Fig. 4). No significant differences in spine density of basal
dendrites were found between the groups (1.3 ± 0.15 vs.
1.07±0.09 spines/μm, respectively; p=0.2). The density of
spines was also similar in the apical dendritic tree (1.6±0.12
vs. 1.17±0.11 spines/μm, respectively; p=0.9).
Corticosterone and AMPA, NMDA, and GABAA receptor
subunits
Repeated treatment with corticosterone did not alter protein
levels of GluA1 and GluA2 subunits of the AMPA receptor
(Fig. 5a1–a2). Also protein levels of GluN1, GluN2A, and
GluN2B subunits of the NMDA receptor (Fig. 5b1–b3) as well
as that of α1, β2, and γ2 subunits of the GABAA receptor
(Fig. 5c1–c3) were not affected.
Longevity of the corticosterone-induced effect
In a separate group of animals, the mean frequency and am-
plitude of sEPSCs were compared between slices prepared 2,
4, or 7 days after the end of the corticosterone treatment lasting
for 7 days. As illustrated in Fig. 6a, the mean frequency of
sEPSCs measured in slices prepared 4 days after the end of the
treatment was not significantly different from that measured
2 days after the treatment ended. In contrast, in slices prepared
7 days after the last corticosterone administration, the mean
frequency of the sEPSCs was not different from the control,
receiving the vehicle (p=0.236). In all cases, the mean am-
plitude of sEPSCs did not deviate from control (Fig. 6b).
The analysis did not reveal a significant effect of treat-
ment [F = 0.753; p = 0.388], time [F = 2.239; p = 0.112],
nor significant interaction between time and treatment
[F= 0.0201; p= 0.98].













1× Tween 1.01± 0.14 28.11 ± 5.50 3.22± 0.17 12.48 ± 2.10 10
1× Corticosterone 1.02± 0.17 29.45 ± 3.78 2.69± 0.37 14.53 ± 1.87 6
7d Tween 1.28± 0.13 32.41 ± 2.52 2.54± 0.16 17.76 ± 1.25 13
7d Corticosterone 1.11 ± 0.12 28.85 ± 2.32 2.69± 0.16 15.50 ± 1.26 8
Differences between values for experimental (corticosterone) and control (Tween) groups, receiving injections
once (1×) or repeatedly for 7 days (7d) are not significant (p > 0.05)
n number of cells
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Discussion
We have previously reported that glutamatergic field poten-
tials evoked in layer II/III of the frontal cortical area M1 by
stimulation of underlying sites were increased after repeated
corticosterone administration lasting 7 and 21 days. Cortico-
sterone treatment has been found to increase the mean fre-
quency, but not the mean amplitude, of sEPSCs in a sample
of layer II/III pyramidal neurons [4]. In the present study, we
have extended those findings by showing that corticosterone
treatment-induced increase in the frequency of sEPSCs is ab-
sent after a single injection of the hormone when tested 2 days
later and, moreover, in the same population of neurons, neither
single nor repeated corticosterone injections affected sIPSCs.
We also show that the sodium channel blocker tetrodotoxin
does not significantly change the mean frequency of sEPSCs
in layer II/III pyramidal cells of the M1 area, indicating that
most of the recorded spontaneous currents correspond to ac-
tion potential-independent miniature EPSCs (mEPSCs; this
study and [45; 48]). The observed increase in the mean fre-
quency of sEPSCs is consistent with a presynaptic mechanism
of the effect, related to an enhanced spontaneous release of
glutamate quanta from presynaptic terminals. This conclusion
is supported by a lack of changes in the protein level of the
tested subunits of postsynaptic ionotropic receptors as well as
with a lack of changes in the density of dendritic spines. Pres-
ent data also demonstrate that membrane excitability of the
recorded cells remains unchanged when tested 2 days after the
end of corticosterone treatment and are consistent with the
observation that direct effects of corticosterone on neuronal
excitability decline to baseline values within hours [16].
The influence of repeated stress or exogenous corticoste-
rone treatment on synaptic transmission in the rat M1 has not
been investigated previously. Earlier studies aimed at finding
cellular and molecular mechanisms underlying the influence
of stress on cortical glutamatergic transmission have mainly
been focused on the medial prefrontal cortex. It was demon-
strated that restraint stress (2 h/day) and unpredictable stress
chosen from six stressors, when repeated for 5–7 days, induce
a reduction in the amplitude of stimulation-evoked and mini-
ature EPSCs [51]. Since these effects were accompanied by
reduced protein levels of AMPA and NMDA receptor sub-
units but unchanged paired-pulse ratio of the evoked EPSCs,
their mechanisms are mainly postsynaptic. These authors have
also found that the frequency of mEPSCs was decreased, im-
plying a contribution of a presynaptic mechanism. Another
study has shown that 21 days of chronic unpredictable stress
resulted in a reduction in both the frequency and the amplitude
of sEPSCs, accompanied by a decrease in the expression level
of several pre- and postsynaptic proteins [24]. On the other
hand, Ito et al. [2010] have found no change in field potentials
and mEPSCs in the anterior cingulate cortex of mice subjected
to restraint lasting 2 h/day for 7 days. However, these authors
observed a reduction in the frequency of IPSCs. The diverse
outcomes of cited and our studies may result from the use of
different experimental models but it is also likely that the
responses of different cortical areas to stress are diverse. For
example, while in the rat mPFC, the dendritic length and spine
density decrease after stress, in the orbitofrontal cortex, they
increase [22].
It has been reported that repeated corticosterone adminis-
tration (40 mg/kg) for 21 days increased the immobility in the
forced swim test, while repeated restraint stress had no effect
on this depression-like behavior [11]. A lower dose of corti-
costerone (20 mg/kg per day), similar to that used in the pres-
ent study, has also been found to increase immobility in the
forced swim test [13]. The effects of repeated stress on the rat
M1 have not yet been investigated; however, it is likely that
they would be weaker than the effects of repeated corticoste-
rone administration. The responses of the organism to repeat-
ed homotypic stress show the adaptive reduction, a phenom-
enon regarded as a form of habituation (reviewed in [12]). A
contribution of the adaptation appears to be smaller in the
unpredictable stress paradigms, however, it has been demon-
strated by several authors that behavioral stress-induced cor-
ticosterone level increases are transient while repeated
Fig. 4 Repeated administration of corticosterone does not change the
density of dendritic spines in layer II/III pyramidal cells. a1, a2
Representative images of dendritic segments of neurons originating
from a control rat (a1) and an animal receiving corticosterone for 7 days
(a2); scale bars= 10 μm. b Corticosterone (Cort) treatment lasting 7 days
(7d) did not affect the density of spines on total (apical + basal), apical nor
basal dendrites compared to neurons originating from rats receiving
vehicle (7d Tw). Spine density is defined as the mean number of spines
per micrometer of dendrite length. The differences are not statistically
significant
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corticosterone administration-induced elevation of plasma
corticosterone level lasts for about 24 h after the last injection
[7, 11, 46]. Thus, repeated corticosterone injections are likely
to exert a stronger influence on the plasma corticosterone level
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than repeated stress sessions. As a consequence, for example,
repeated corticosterone-treated rats weigh less than the ani-
mals subjected to repeated restraint [28]. In our study after
7 days of treatment, the difference was not significant, which
may be attributed to the selected dose of corticosterone (cf.
[11]). Interestingly, our data show that despite a prolonged
exposure to elevated levels of corticosterone, no changes were
evident in the GABAergic input to layer II/III pyramidal neu-
rons, in contrast to the glutamatergic one. On the other hand,
decreased levels of GABA and GABAergic transmission have
been found in the prefrontal cortex of animals subjected to
chronic mild stress and chronic social defeat stress [14, 47].
Again, the use of not only a different experimental model but
also different responses to corticosterone of different cortical
areas are likely reasons of the apparent discrepancy.
Our data demonstrate that corticosterone treatment did not
influence the protein levels of GluA1, GluA2, GluN1,
GluN2A, and GluN2B subunits of ionotropic glutamate re-
ceptors or that of α1, β2, and γ2 subunits of the GABAA
receptor in the rat motor cortex. Other studies showed changes
in the expression levels of some receptor subunits in other
cortical areas. It has been reported that repeated corticosterone
administration for 14 days resulted in a decrease in the expres-
sion level of GluN2B and GluA2/3 subunit proteins in the rat
medial prefrontal cortex, but no changes were evident in either
adjacent lateral orbitofrontal cortex or the hippocampus [10].
Regarding the GABAergic system, corticosterone-treated rats
expressed altered protein level of theα2, but not other subunits
of the GABAA receptor in the hippocampus [28]. In contrast
to the cortex, no effects of repeated stress on basal glutamater-
gic transmission were detected in the striatum, hippocampal
CA1 area [51], and the dentate gyrus [18].
Several studies have shown that chronic treatment of rats
with antidepressant drugs reduces excitatory synaptic trans-
mission (reviewed in [31]). We have previously demonstrated
that repeated administration of a tricyclic antidepressant imip-
ramine, lasting for 2 weeks, attenuates glutamatergic transmis-
sion in the rat frontal cortex by decreasing the mean frequency
and, to a lesser degree, the mean amplitude of sEPSCs [45].
Imipramine adminis t ra t ion normal ized repeated
corticosterone-induced increase in the field potential ampli-
tude and sEPSC frequency and, moreover, restored
corticosterone-impaired potential for the induction of long-
term potentiation in the frontal cortex [4]. These data suggest
that the influence of imipramine on glutamatergic transmis-
sion is opposite to that of repeated corticosterone administra-
tion. Our earlier work also showed that imipramine adminis-
tration counteracted repeated corticosterone-induced function-
al modifications in the reactivity of 5-HT1A and 5-HT2 recep-
tors in the rat frontal cortex [52].
Acute stress and single episodes of exposure to corticoste-
rone transiently increase the release of glutamate from presyn-
aptic terminals in the prefrontal and frontal cortex (reviewed
in [34]). It is conceivable that repeated episodes of transient
enhancement of excitatory transmission via pre- and/or post-
synaptic mechanisms [50] may eventually induce a sustained
modification of glutamate release via activity-dependent
mechanisms.
Spontaneous excitatory postsynaptic events, previously
regarded as mere synaptic noise, have been proposed to play
a key role in a homeostatic regulation of synaptic efficacy by
controlling dendritic protein synthesis [43]. It has been dem-
onstrated that the level of spontaneous glutamate release ad-
justs the plasticity threshold at single synapses, thus
representing a form of metaplasticity [23]. In line with these
results, our previous study demonstrated that repeated corti-
costerone administration-induced enhancement of spontane-
ous excitatory transmission coincides with a reduced possibil-
ity for LTP induction in the rat motor cortex [4]. Of note,
blockade of the NMDA component of spontaneous EPSCs
has been implicated in a rapid antidepressant-like effect of
ketamine and other NMDA receptor antagonists in animal
models [2].
In summary, we demonstrate that repeated exogenous cor-
ticosterone administration to the adolescent rats results, by a
currently unknown mechanism, in an increase in the frequen-
cy of sEPSCs, but not other parameters characterizing the
glutamatergic input to layer II/III pyramidal neurons of the
M1. Furthermore, we show that the GABAergic transmission
remains unchanged after corticosterone treatment. These find-
ings add to a growing body of evidence that chronically
Fig. 5 Western blot analysis of AMPA, NMDA, and GABAA receptor
subunit proteins in the M1. Bar graphs represent summary results of the
densitometric analysis of subunit proteins from the motor cortex of rats
treated with corticosterone for 7 days (mean ± SEM; black bars) with
respective controls, receiving vehicle (white bars). The differences are
not statistically significant. In each bar, n = 6–8. The above bar graphs
show computerized scans of representative Western immunoblots
illustrating subunit protein bands in corticosterone-treated and control
groups as well as GAPDH bands
Fig. 6 Longevity of corticosterone-induced effect on the frequency of
sEPSCs in layer II/III M1 pyramidal neurons. a The mean frequency of
the sEPSCs recorded 2, 4, or 7 days after last drug administration from
neurons obtained from animals treated with Tween or corticosterone for
7 days. *, #p < 0.05; **, ##p< 0.01. b Themean amplitude of the sEPSCs
recorded 2, 4, or 7 days after last drug administration from neurons from
animals treated with Tween or corticosterone for 7 days
Pflugers Arch - Eur J Physiol (2016) 468:679–691 689
elevated corticosterone level results in a distortion of the bal-
ance between glutamate and GABA system in the brain.
In conclusion, we propose that corticosterone treatment
evoked potentiation of glutamatergic transmission in the mo-
tor cortex and constitutes the potential mechanisms underly-
ing detrimental influence of stress on skilled movement pat-
terns and skilled movement accuracy in M1-dependent
reaching and walking tasks [29].
Acknowledgments The present study was supported by the National
Science Centre, Poland, grant no. DEC-2012/07/B/NZ4/01669
Compliance with ethical standards Experimental procedures were
approved by the Animal Care and Use Committee at the Jagiellonian
University and were carried out in accordance with the European
Community guidelines for the use of experimental animals and the
national law.
Open Access This article is distributed under the terms of the
Creative Commons Attribution 4.0 International License (http://
creativecommons.org/licenses/by/4.0/), which permits unrestricted
use, distribution, and reproduction in any medium, provided you give
appropriate credit to the original author(s) and the source, provide a link
to the Creative Commons license, and indicate if changes were made.
References
1. Antonow-Schlorke I, Ehrhardt J, Knieling M (2013) Modification
of the ladder walking task—new options for analysis of skilled
movements. Stroke Res Treat 2013:418627. doi:10.1155/2013/
418627
2. Autry AE, Adachi M, Nosyreva E, Na ES, Los MF, Cheng PF,
Kavalali ET, Monteggia LM (2011) NMDA receptor blockade at
rest triggers rapid behavioural antidepressant responses. Nature
475(7354):91–95. doi:10.1038/nature10130
3. Bekisz M, Garkun Y, Wabno J, Hess G, Wrobel A, Kossut M
(2010) Increased excitability of cortical neurons induced by asso-
ciative learning: an ex vivo study. Eur J Neurosci 32(10):1715–
1725. doi:10.1111/j.1460-9568.2010.07453.x
4. Bobula B, Wabno J, Hess G (2011) Imipramine counteracts
corticosterone-induced enhancement of glutamatergic transmission
and impairment of long-term potentiation in the rat frontal cortex.
Pharmacol Rep 63(6):1404–1412
5. Checkley S (1996) The neuroendocrinology of depression and
chronic stress. Br Med Bull 52(3):597–617
6. Cull-Candy S, Brickley S, Farrant M (2001) NMDA receptor sub-
units: diversity, development and disease. Curr Opin Neurobiol
11(3):327–335
7. Czyrak A,MaćkowiakM, ChocykA, FijałK, Tokarski K, BijakM,
Wedzony K (2002) Prolonged corticosterone treatment alters the
responsiveness of 5-HT1A receptors to 8-OH-DPAT in rat CA1
hippocampal neurons. Naunyn Schmiedeberg’s Arch Pharmacol
366(4):357–367
8. Donoghue JP, Wise SP (1982) The motor cortex of the rat:
cytoarchitecture and microstimulation mapping. J Comp Neurol
212(1):76–88
9. Gilabert-Juan J, Castillo-Gomez E, Guirado R, Moltó MD, Nacher
J (2012) Chronic stress alters inhibitory networks in the medial
prefrontal cortex of adult mice. Brain Struct Funct 218(6):1591–
1605. doi:10.1007/s00429-012-0479-1
10. Gourley SL, Kedves AT, Olausson P, Taylor JR (2009) A history of
corticosterone exposure regulates fear extinction and cortical
NR2B, GluR2/3, and BDNF. Neuropsychopharmacology 34(3):
707–16. doi:10.1038/npp.2008.123
11. Gregus A, Wintink AJ, Davis AC, Kalynchuk LE (2005)
Effect of repeated corticosterone injections and restraint stress
on anxiety and depression-like behavior in male rats. Behav
Brain Res 156(1):105–114
12. Grissom N, Bhatnagar S (2009) Habituation to repeated stress: get
used to it. Neurobiol Learn Mem 92(2):215–224. doi:10.1016/j.
nlm.2008.07.001
13. Hill MN, Brotto LA, Lee TT, Gorzalka BB (2003) Corticosterone
attenuates the antidepressant-like effects elicited bymelatonin in the
forced swim test in both male and female rats. Prog
Neuropsychopharmacol Biol Psychiatry 27(6):905–911
14. Ito H, Nagano M, Suzuki H, Murakoshi T (2010) Chronic stress
enhances synaptic plasticity due to disinhibition in the anterior cin-
gulate cortex and induces hyper-locomotion in mice.
Neuropharmacology 58(4–5):746–757. doi:10.1016/j.neuropharm.
2009.12.011
15. Jadavji NM, Supina RD, Metz GA (2011) Blockade of mineralo-
corticoid and glucocorticoid receptors reverses stress-induced mo-
tor impairments. Neuroendocrinology 94(4):278–290. doi:10.1159/
000329988
16. Joëls M (2011) Impact of glucocorticoids on brain function: rele-
vance for mood disorders. Psychoneuroendocrinology 36(3):406–
414. doi:10.1016/j.psyneuen.2010.03.004
17. Johnstone GA (2005) GABAA receptor channel pharmacology.
Curr Pharm Des 11(15):1867–1885
18. Karst H, Joëls M (2003) Effect of chronic stress on synaptic cur-
rents in rat hippocampal dentate gyrus neurons. J Neurophysiol
89(1):625–633
19. Kleim JA, Barbay S, Nudo RJ (1998) Functional reorganization of
the rat motor cortex following motor skill learning. J Neurophysiol
80(6):3321–3325
20. Kleim JA, Lussnig E, Schwarz ER, Comery TA, Greenough WT
(1996) Synaptogenesis and Fos expression in the motor cortex of
the adult rat after motor skill learning. J Neurosci 16(14):4529–
4535
21. Kirkland SW, Smith L, Metz GA (2012) Task-specific compensa-
tion and recovery following focal motor cortex lesion in stressed
ra t s . J I n t eg r Neurosc i 11 (1 ) : 33–59 . do i :10 .1142 /
S0219635212500033
22. Kolb B, Gibb R (2015) Plasticity in the prefrontal cortex of adult
rats. Front Cell Neurosci 9:15. doi:10.3389/fncel.2015.00015
23. Lee MC, Yasuda R, Ehlers MD (2010) Metaplasticity at single
glutamatergic synapses. Neuron 66(6):859–870. doi:10.1016/j.
neuron.2010.05.015
24. Li N, Liu RJ, Dwyer JM, Banasr M, Lee B, Son H, Li XY,
Aghajanian G, Duman RS (2011) Glutamate N-methyl-D-
aspartate receptor antagonists rapidly reverse behavioral and syn-
aptic deficits caused by chronic stress exposure. Biol Psychiatry
69(8):754–761. doi:10.1016/j.biopsych.2010.12.015
25. Lopez JF, Chalmers DT, Little KY,Watson SJ (1998) Regulation of
serotonin1A, glucocorticoid, and mineralocorticoid receptor in rat
and human hippocampus: implications for the neurobiology of de-
pression. Biol Psychiatry 43(8):547–573
26. Lu W, Shi Y, Jackson AC, Bjorgan K, During MJ, Sprengel R,
Seeburg PH, Nicoll RA (2009) Subunit composition of synaptic
AMPA receptors revealed by a single-cell genetic approach.
Neuron 62(2):254–268. doi:10.1016/j.neuron.2009.02.027
27. Luscher B, Keller CA (2004) Regulation of GABAA receptor traf-
ficking, channel activity, and functional plasticity of inhibitory syn-
apses. Pharmacol Ther 102(3):195–221
28. Lussier AL, Romay-Tallón R, Caruncho HJ, Kalynchuk LE (2013)
Altered GABAergic and glutamatergic activity within the rat
690 Pflugers Arch - Eur J Physiol (2016) 468:679–691
hippocampus and amygdala in rats subjected to repeated corticoste-
rone administration but not restraint stress. Neuroscience 231:38–
48. doi:10.1016/j.neuroscience.2012.11.037
29. Metz GA, Jadavji NM, Smith LK (2005) Modulation of motor
function by stress: a novel concept of the effects of stress and cor-
ticosterone on behavior. Eur J Neurosci 22(5):1190–1200
30. MorimotoM,Morita N, Ozawa H, Yokoyama K, KawataM (1996)
Distribution of glucocorticoid receptor immunoreactivity and
mRNA in the rat brain: an immunohistochemical and in situ hy-
bridization study. Neurosci Res 26(3):235–269
31. Musazzi L, Treccani G, Mallei A, Popoli M (2013) The action of
antidepressants on the glutamate system: regulation of glutamate
release and glutamate receptors. Biol Psychiatry 73(12):1180–
1188. doi:10.1016/j.biopsych.2012
32. Nudo RJ, Jenkins WM, Merzenich MM (1990) Repetitive
microstimulation alters the cortical representation of movements
in adult rats. Somatosens Mot Res 7(4):463–483
33. Parker KJ, Schatzberg AF, Lyons DM (2003) Neuroendocrine as-
pects of hypercortisolism in major depression. Horm Behav 43(1):
60–66
34. Popoli M, Yan Z, McEwen BS, Sanacora G (2011) The stressed
synapse: the impact of stress and glucocorticoids on glutamate
transmission. Nat Rev Neurosci 13(1):22–37. doi:10.1038/nrn3138
35. Reimers JM, Milovanovic M, Wolf ME (2011) Quantitative analy-
sis of AMPA receptor subunit composition in addiction-related
brain regions. Brain Res 1367:223–233. doi:10.1016/j.brainres.
2010.10.016
36. RempleMS, Bruneau RM, VandenBerg PM,Goertzen C, Kleim JA
(2001) Sensitivity of cortical movement representations to motor
experience: evidence that skill learning but not strength training
induces cortical reorganization. Behav Brain Res 123(2):133–141
37. Rioult-Pedotti MS, Donoghue JP, Dunaevsky A (2007) Plasticity of
the synaptic modification range. J Neurophysiol 98(6):3688–3695
38. Rioult-Pedotti MS, Friedman D, Donoghue JP (2000) Learning-
induced LTP in neocortex. Sci (Wash) 290(5491):533–536
39. Rioult-Pedotti MS, Friedman D, Hess G, Donoghue JP (1998)
Strengthening of horizontal cortical connections following skill
learning. Nat Neurosci 1(3):230–234
40. Roland BL, Krozowski ZS, Funder JW (1995) Glucocorticoid re-
ceptor, mineralocorticoid receptors, 11 beta-hydroxysteroid dehy-
drogenase-1 and -2 expression in rat brain and kidney: in situ stud-
ies. Mol Cell Endocrinol 111(1):R1–7
41. Shansky RM, Morrison JH (2009) Stress-induced dendritic remod-
eling in the medial prefrontal cortex: effects of circuit, hormones
and rest. Brain Res 1293:108–113. doi:10.1016/j.brainres.2009.03.
062
42. Sterner EY, Kalynchuk LE (2010) Behavioral and neurobiological
consequences of prolonged glucocorticoid exposure in rats: rele-
vance to depression. Prog Neuropsychopharmacol Biol Psychiatry
34(5):777–790. doi:10.1016/j.pnpbp.2010.03.005
43. SuttonMA,Wall NR, Aakalu GN, Schuman EM (2004) Regulation
of dendritic protein synthesis by miniature synaptic events. Science
304(5679):1979–1983
44. Tokarski K, Urban-Ciecko J, Kossut M, Hess G (2007) Sensory
learning-induced enhancement of inhibitory synaptic transmission
in the barrel cortex of the mouse. Eur J Neurosci 26(1):134–141
45. Tokarski K, Bobula B, Wabno J, Hess G (2008) Repeated admin-
istration of imipramine attenuates glutamatergic transmission in rat
frontal cortex. Neuroscience 153(3):789–795. doi:10.1016/j.
neuroscience.2008.03.007
46. van Gemert NG, van Riel E,Meijer OC, Fehr S, SchachnerM, Joëls
M (2006) No effect of prolonged corticosterone over-exposure on
NCAM, SGK1, and RGS4 mRNA expression in rat hippocampus.
Brain Res 1093(1):161–166
47. Venzala E, García-García AL, Elizalde N, Tordera RM (2013)
Social vs. environmental stress models of depression from a behav-
ioural and neurochemical approach. Eur Neuropsychopharmacol
23(7):697–708. doi:10.1016/j.euroneuro.2012.05.010
48. Wabno J, Hess G (2013) Repeated administration of imipramine
modifies GABAergic transmission in rat frontal cortex. J Neural
Transm 120(5):711–719. doi:10.1007/s00702-012-0919-3
49. Whishaw IQ (2000) Loss of the innate cortical engram for action
patterns used in skilled reaching and the development of behavioral
compensation following motor cortex lesions in the rat.
Neuropharmacology 39(5):788–805
50. Yuen EY, Liu W, Karatsoreos IN, Ren Y, Feng J, McEwen BS, Yan
Z (2011) Mechanisms for acute stress-induced enhancement of glu-
tamatergic transmission and working memory. Mol Psychiatry
16(2):156–170. doi:10.1038/mp.2010.50
51. Yuen EY, Wei J, Liu W, Zhong P, Li X, Yan Z (2012) Repeated
stress causes cognitive impairment by suppressing glutamate recep-
tor expression and function in prefrontal cortex. Neuron 73(5):962–
977. doi:10.1016/j.neuron.2011.12.033
52. Zahorodna A, Hess G (2006) Imipramine and citalopram reverse
corticosterone-induced alterations in the effects of the activation of
5-HT1A and 5-HT2 receptors in rat frontal cortex. J Physiol
Pharmacol 57(3):389–399
Pflugers Arch - Eur J Physiol (2016) 468:679–691 691
